Knee pain relief without surgery? collagen injection shows promise

NCT ID NCT02539095

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested whether injecting a collagen product called CartiZol into the knee can reduce pain in people with osteoarthritis, cartilage damage, or injury-related arthritis. 200 adults with knee pain received either the collagen injection or a placebo (saline). The main goal was to measure pain levels 24 weeks after the injection using a standard pain scale. The trial is complete, and results may show whether this simple injection offers a new way to manage knee pain.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
CartiZol (absorbable collagen injection)
What this could lead to
If it works, this could offer a simple injection to ease knee pain from arthritis or injury, potentially delaying or avoiding surgery.
What could go wrong
This is a single completed Phase 4 trial with 200 participants. The effect may be modest, and not everyone may benefit. Long-term safety and effectiveness are not yet fully known.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHONDROMALACIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Chung-Ang University Hospital

    Seoul, South Korea

  • Kunkuk University Medical Center

    Seoul, South Korea

  • Samsung Medical Center

    Seoul, South Korea

  • The Catholic University of Korea, Seoul St. Mary's Hospital

    Seoul, South Korea

  • The Catholic University of Korea, Yeouido St. Mary's Hospital

    Seoul, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.